Presidential Determination on Major Drug Transit or Major Illicit Drug Producing Countries for Fiscal Year 2027
Record date: 2026-09-18
Presidential Determination No. 2026-23 of September 11, 2026 Presidential Determination on Major Drug Transit or Major Illicit Drug Producing Countries for Fiscal Year 2027 Memorandum for the Secretary of State By the authority vested in me as President by the Constitution and the laws of the United States, including section 706(1) of the Foreign Relations Authorization Act, Fiscal Year 2003 ( Public Law 107-228 ) (FRAA), I hereby identify the following countries as major drug transit or major illicit drug producing countries: Afghanistan, The Bahamas, Belize, Bolivia, Burma, the People's
What this record contains
- Federal Register document
- 2026-19251
- Publication date
- 2026-09-18
- Citation
- 91 FR 59687
- Issuing office
- Executive Office of the President
Official record excerpt
Presidential Determination No. 2026-23 of September 11, 2026 Presidential Determination on Major Drug Transit or Major Illicit Drug Producing Countries for Fiscal Year 2027 Memorandum for the Secretary of State By the authority vested in me as President by the Constitution and the laws of the United States, including section 706(1) of the Foreign Relations Authorization Act, Fiscal Year 2003 ( Public Law 107-228 ) (FRAA), I hereby identify the following countries as major drug transit or major illicit drug producing countries: Afghanistan, The Bahamas, Belize, Bolivia, Burma, the People's Republic of China (PRC), Colombia, Costa Rica, the Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, India, Jamaica, Laos, Mexico, Nicaragua, Pakistan, Panama, Peru, and Venezuela. A country's presence on the foregoing list is not necessarily a reflection of its government's counterdrug efforts or level of cooperation with the United States. Consistent with the statutory definition of a major drug transit or major illicit drug producing country set forth in sections 481(e)(2) and 481(e)(5) of the Foreign Assistance Act of 1961, as amended (Public Law 87-195) (FAA), the reason countries are placed on the list is the combination of geographic, commercial, and economic factors that allow drugs or precursor chemicals to be transited or produced, even if a government has engaged in robust and diligent narcotics control and law enforcement measures. Pursuant to section 706(2)(A) of the FRAA, I hereby designate Afghanistan, Bolivia, Burma, and Colombia as having failed demonstrably during the previous 12 months to make substantial efforts to adhere to their obligations under international counternarcotics agreements and to take the counternarcotics measures required by section 489 of the FAA Included with this determination are justifications for the designations of Afghanistan, Bolivia, Burma, and Colombia, as required by section 706(2)(B) of the FRAA. I have also determined, in accordance with the provisions of section 706(3)(A) of the FRAA, that United States assistance to Bolivia, Burma, and Colombia is vital to the national interests of the United States. My Administration has made historic progress in protecting the American people from deadly drugs and vicious narcoterrorist organizations. Under my Administration, our southern border is the most sealed and secure in American history, thanks to the largest investments in border security and law enforcement in our Nation's history. After 4 years of open border chaos, seizures of fentanyl and other drugs being smuggled into the United States have been reduced by more than half, and drug overdose deaths have plunged. My Administration has saved tens of thousands of American lives from this scourge. The narcoterrorists responsible for this invasion are either dead, in jail, or living in fear knowing they will be next to face American justice. I have unleashed the strongest military in the history of the world to strike narcoterrorists wherever they threaten our country. Behind the might of the American military, my Administration has destroyed cartel infrastructure, shut down former trafficking highways across sea and land borders, and captured and killed hundreds of the most vicious narcoterrorists. Under the Americas Counter Cartel Coalition, an alliance with over a dozen countries in the Western Hemisphere, we have achieved historic results, ( printed page 59688) drastically reducing United States-bound drug flows and seizing billions of dollars of illicit cartel finances. United States law enforcement agencies are reporting record drug seizures, and our allies are extraditing more cartel bosses to the United States than ever before. We have inflicted unprecedented losses on our enemies, and we are just getting started. While my Administration has successfully secured our borders from invasion, Canada and Mexico need to do far more to stop the flows of deadly drugs into our country. Fentanyl continues to be illicitly produced in clandestine Canadian labs, and precursor chemicals and synthetic drugs continue to enter the United States through Canada. Canada needs to take meaningful action to dismantle drug labs, strengthen supply chain security, and degrade criminal networks and Chinese gangs operating along our northern border. We recognize Mexican President Sheinbaum's administration for seizing greater volumes of drugs, dismantling clandestine laboratories, and deploying additional law enforcement and military resources to our shared border. Additionally, United States-Mexican security cooperation has helped eliminate some of the world's most notorious cartel bosses, including
The excerpt is reproduced from the public federal record and may omit later sections, tables, signatures or attachments. Open the official source for the complete text.
Questions for accountability
- What legal authority does this foreign policy action cite?
- Which agencies or officials were directed to act?
- What measurable implementation, cost, deadline or later court action followed?
How to use this page
This is a source-record entry, not a truth-rating by itself. It preserves the action, date and original government publication so it can be connected to later claims, implementation records, court decisions, costs and measurable outcomes. Editorial claim reviews on this site use separate finding labels and explain the evidence for those findings.